
A recent study conducted by Eli Lilly shows positive effects of the use of diabetes drug tirzepatide.
In fact, all primary study outcomes were met in the trial that compared the effect of tirzepatide with the older treatment insulin glargine – also known by the brand name Lantus.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app